Section Arrow
Quote
CVKD.NASDAQ
- Cadrenal Therapeutics Inc
Quotes are at least 15-min delayed:2025/06/02 00:17 EDT
Last
 13.33
-0.035 (-0.26%)
Day High 
13.5945 
Prev. Close
13.365 
1-M High
17 
Volume 
12.76K 
Bid
13.01
Ask
14.15
Day Low
13.25 
Open
13.25 
1-M Low
13 
Market Cap 
26.28M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 14.87 
20-SMA 15.11 
50-SMA 16.27 
52-W High 22.9011 
52-W Low 5.7 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-9.26/-3.38
Enterprise Value
26.28M
Balance Sheet
Book Value Per Share
3.11
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
INABIN8bio0.1446-0.0088-5.74%-- 
BLRXBioLineRx Ltd5.18+1.3891+36.64%-- 
IMNNImunon2.45+0.46+23.12%-- 
NCNANuCana plc0.03525-0.00175-4.73%-- 
MRNAModerna26.58-0.35-1.30%-- 
Quotes are at least 15-min delayed：2025/06/02 00:17 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.